Addressing New Requirements Under the FY24 Medicare Inpatient Prospective Payment System (IPPS) Rule
Healthcare providers are facing a difficult financial environment, characterized by cost increases, labor shortages, supply chain disruption, and reimbursement decreases.
At the same time, new regulatory requirements are placing significant resource burdens on a labor force that is already stretched thin. These new regulatory requirements lead to greater audit scrutiny and risk of compliance issues, which can further jeopardize reimbursement and lead to expensive penalties.
The Centers for Medicare & Medicaid Services (CMS) Inpatient Prospective Payment System (IPPS) 2024 rule, which was released on August 1, 2023, decreased reimbursement for uncompensated care (UCC) and Disproportionate Share Hospital (DSH) payments by $950 million. The new rule increases risks regarding Medicaid eligible days, which jeopardizes DSH payments and 340B eligibility. Expansion of reporting requirements for Medicare bad debts, DSH, UCC, and total bad debts further increase the risk of lost reimbursement and compliance issues.
In addition to the IPPS 2024 rule, the Health Equity CMS framework is expanding in FY24, meaning hospitals will need to implement new processes to capture health equity data appropriately. These requirements add an additional layer of complexity for organizations already trying to adhere to the new IPPS rule.
To be successful in the year ahead, healthcare organizations will need to find ways to decrease costs, improve quality of care, increase reimbursement, and improve margins, all while remaining compliant with the new IPPS rule.
UCC Payments, DSH Payments, and 340B Eligibility
The $950 million reduction in reimbursement for UCC and DSH payments means organizations must be more diligent in reporting reimbursement components.
CMS also used this rule to finalize the proposed change to Section 1115 regarding days that can be included in the Medicaid fraction of the DSH payment calculation, resulting in a decrease in Medicare DSH payments. The days reduction could significantly impact 340B qualification as well as increase the risk of hospitals not qualifying for DSH and UCC payments.
Improperly reported Medicaid Eligible Days could result in:
- A decrease in or elimination of DSH reimbursement
- Loss of 340B eligibility, should the DSH percentage fall below the 340B threshold
The potential impact to UCC could include:
- Failure to obtain hospital’s full UCC reimbursement due to processes not capturing all charity care and bad debts
- Loss of expected reimbursement due to noncompliance with Medicare regulations
Additional Reporting Requirements for Medicare Bad Debts, Medicaid Eligible Days for DSH, Charity Care Reporting, and Total Bad Debts
Prior to the FY24 rule issuance, on December 29, 2022, Transmittal 18 was released. This transmittal was effective for all cost reports beginning after October 1, 2022. The first cost reporting period affected by these changes is Fiscal Year End (FYE): September 30, 2023. Specifically, the transmittal implemented additional exhibits or changes to existing exhibits for reporting of the following data:
|
Medicare bad debts |
Medicaid Eligible Days for DSH |
Charity care charges by patient |
Total bad debts by patient |
The new requirements introduce or revise the reporting of elements for these areas, which will increase the complexity of reporting for reimbursement on the Medicare cost report. Along with the additional work involved, these new requirements will also bring increased compliance scrutiny and Medicare Administrative Contractor (MAC) audit risk, which could lead to reduced payments or complete elimination of payments for Medicare bad debts, DSH, and UCC, which may result in loss of 340B eligibility.
Health Equity
The final rule continues to expand on the CMS Framework for Health Equity 2022-2032, adding 15 new health equity elements. This plan puts forth measures for hospitals to document the impact of their health equity policies on their patient population and outlines five priorities:
|
1 |
2 |
3 |
4 |
5 |
|
Expand the collection, reporting, and analysis of standardized health equity data
|
Assess the cause of disparities within CMS programs and address inequities in policies and operations to close gaps
|
Build the capacity of healthcare organizations and the workforce to reduce health and healthcare disparities |
Advance language access, health literacy, and the provision of culturally tailored services |
Increase all forms of accessibility to healthcare services and coverage |
These health equity measures will be incorporated into reimbursement methodologies. In addition, providers can receive bonus payments called the Health Equity Adjustment Bonus. Through this methodology they can also earn up to 10 bonus points in their Hospital Value Based score.
The new health equity elements fall under three different categories:
|
Category |
Optional |
Mandatory |
|
Facility Commitment to Measure Health Equity |
FY25
|
FY26 |
|
Screening for Social Drivers of Health |
FY26 |
FY27 |
|
Screen Positive Rate for Social Drivers of Health |
FY26 |
FY27 |
Final Thoughts
The final FY24 IPPS rule will have a significant impact on reimbursement rates for healthcare organizations, as well as the resources needed to maintain compliance with the IPPS. To meet these new requirements, healthcare organizations may need to work with a third party, who can provide additional specialized resources and knowledge that may not be available in house.
Copyright © 2023 BDO USA, P.A. All rights reserved. www.bdo.com
To read the FY 2024 IPPS/LTCH PPS final rule in full, click here.